Abstract
Aortic arch endografting will undoubtedly expand the population suitable for aortic arch repair. Currently, there are four endografts under investigation to treat aortic arch pathology including Gore's Thoracic Branch Endoprosthesis, Endospan's NEXUS Aortic Arch Stent Graft System, Terumo's RelayBranch Thoracic Stent-Graft System, and Cook's Zenith Arch Branched Graft. Despite advances in deployment technique, self-aligning features to mitigate aortic arch manipulation, and distal embolic protection, perioperative stroke continues to be high, limiting the devices from commercial availability. Here we discuss current devices under trial in the United States, limitations of aortic arch endografting, and future directions.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.